- $21.00m
- $28.98m
- $50.35m
- 20
- 80
- 54
- 50
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.26 | ||
| Price to Tang. Book | 0.28 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.23 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -24.86% | ||
| Return on Equity | -180.14% | ||
| Operating Margin | -24.54% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 37.08 | 39.68 | 55.41 | 56.24 | 50.35 | 51.29 | 63.98 | 10.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
Directors
- Grigorios Siokas CHM (55)
- Georgios Terzis CFO (39)
- Pavlos Ignatiades COO (58)
- Peter Goldstein EDR (58)
- Demetrios Demetriades SEC (54)
- Dimitrios Goulielmos IND (53)
- John Hoidas IND (55)
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- July 21st, 2009
- Public Since
- May 19th, 2010
- No. of Shareholders
- 482
- No. of Employees
- 102
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 16,932,561
- Address
- 141 W. JACKSON BLVD, SUITE 4236, CHICAGO, 60604
- Web
- https://www.cosmosholdingsinc.com/
- Phone
- +1 3125363102
- Auditors
- Armanino LLP
Upcoming Events for COSM
Q4 2023 Cosmos Health Inc Earnings Release
Q2 2024 Cosmos Health Inc Earnings Release
Cosmos Health Inc Annual Shareholders Meeting
Q3 2024 Cosmos Health Inc Earnings Release
Similar to COSM
60 Degrees Pharmaceuticals
NASDAQ Capital Market
Aadi Bioscience
NASDAQ Capital Market
Acasti Pharma
NASDAQ Capital Market
Agriforce Growing Systems
NASDAQ Capital Market
Aptorum
NASDAQ Capital Market
FAQ
What is the Cosmos Health share price?
As of Today at 20:06 UTC, shares in Cosmos Health are trading at $0.67. This share price information is delayed by 15 minutes.
How has the Cosmos Health share price performed this year?
Shares in Cosmos Health last closed at $0.67 and the price had moved by -78.11% over the past 365 days. In terms of relative price strength the Cosmos Health share price has underperformed the S&P500 Index by -82.58% over the past year.
What are the analyst and broker recommendations for Cosmos Health?
The overall consensus recommendation for Cosmos Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Cosmos Health dividend yield?
Cosmos Health does not currently pay a dividend.
Does Cosmos Health pay a dividend?
Cosmos Health does not currently pay a dividend.
When does Cosmos Health next pay dividends?
Cosmos Health does not currently pay a dividend.
How do I buy Cosmos Health shares?
To buy shares in Cosmos Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cosmos Health?
As of the previous close price of $0.67, shares in Cosmos Health had a market capitalisation of $11.41m.
Where are Cosmos Health shares listed?
Here are the trading details for Cosmos Health:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: COSM
What kind of share is Cosmos Health?
Based on an overall assessment of its quality, value and momentum Cosmos Health is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cosmos Health share price forecast for 2024?
The analyst consensus target price for shares in Cosmos Health is $4.00. That is 493.38% above the last closing price of $0.67.
Analysts covering Cosmos Health currently have a consensus Earnings Per Share (EPS) forecast of -$0.64 for the next financial year.
What is the trend in the Cosmos Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cosmos Health. Over the past six months, its share price has underperformed the S&P500 Index by -57.63%.
As of the last closing price of $0.67, shares in Cosmos Health were trading -30.18% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cosmos Health PE Ratio?
The Cosmos Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.67.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cosmos Health?
Cosmos Health's management team is headed by:
- Grigorios Siokas - CHM
- Georgios Terzis - CFO
- Pavlos Ignatiades - COO
- Peter Goldstein - EDR
- Demetrios Demetriades - SEC
- Dimitrios Goulielmos - IND
- John Hoidas - IND